Conflict of Interest:
Conflicts of Interest are as follows; the remaining co-authors do not have any conflicts of interest.
Bruce Korf:
Robert Kesterson is a lead advisor for
Infixion
David Bedwell is consultant for
PTC Therapeutics, Inc.
Deeann Wallis, Robert Kesterson, and Bruce Korf are inventors on US Provisional Patent Application No. 62/903,521 - Exon skipping to treat Neurofibromatosis Type 1.
Data Sharing: Data Availability Statement: Data available on request from the authors.